Peer Exchange
October 31, 2018 –
Expert panelists Bruce Feinberg, DO; Dana Macher; and Michael Kolodziej, MD, explore different healthcare payment models.
October 31, 2018 –
Expert panelists Bruce Feinberg, DO; Mark S. Soberman, MD, MBA, FACS; Michael Kolodziej, MD; and Dana Macher discuss oncology care within integrated delivery networks.
October 29, 2018 –
Jill Dehlin, RN; Peter Goadsby, MD, PhD; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, discuss payer management strategies and patients’ access to anti-CGRP (calcitonin gene-related peptide) therapy for the management of migraine.
October 29, 2018 –
Jill Dehlin, RN; Peter Goadsby, MD, PhD; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, discuss the appropriateness for initiating erenumab in patients with migraine and review important considerations surrounding how it is dosed and administered.
October 24, 2018 –
Expert panelists Bruce Feinberg, DO; Mark S. Soberman, MD, MBA, FACS; and Michael Kolodziej, MD, examine the unique healthcare model of the Department of Veterans Affairs (VA).
October 24, 2018 –
Expert panelists Mark S. Soberman, MD, MBA, FACS; Bruce Feinberg, DO; Dana Macher; and Michael Kolodziej, MD, examine some best-in-class healthcare delivery models.
October 22, 2018 –
Peter Goadsby, MD, PhD, and Peter L. Salgo, MD, review clinical trial data demonstrating the potential of erenumab for preventive treatment of migraine.
October 22, 2018 –
Peter Goadsby, MD, PhD, and Peter L. Salgo, MD, explain what CGRP (calcitonin gene-related peptide) is and how it relates to novel migraine treatment options.
October 17, 2018 –
Expert panelists Bruce Feinberg, DO; Mark S. Soberman, MD, MBA, FACS; Dana Macher; and Michael Kolodziej, MD, discuss the pros and cons of integrated delivery networks.
October 17, 2018 –
Expert panelists Bruce Feinberg, DO; Mark S. Soberman, MD, MBA, FACS; Michael Kolodziej, MD; and Dana Macher review the role of medium-sized employers in integrated delivery networks.
